Author

J. Sainz de Aja

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

C. Kim· 2 shared A. A. Wilson· 1 shared A. Cupic· 1 shared A. E. Goldfeld· 1 shared A. E. Tseng· 1 shared A. Fernandez-Sesma· 1 shared A. García-Sastre· 1 shared A. J. Hume· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

C. Kim

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintFeb 8, 2022

The oral drug nitazoxanide restricts SARS-CoV-2 infection and attenuates disease pathogenesis in Syrian hamsters

L. Miorin, C. E. Mire, S. Ranjbar…·A. E. Goldfeld

The paper shows that nitazoxanide inhibits SARS-CoV-2 replication and pathogenesis in human and hamster models, and synergizes with remdesivir against multiple variants.

DOI 10.1101/2022.02.08.479634

mouseexperimental assay

𝕏 PostBluesky

Cell BiologybioRxivJun 29, 2020

SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery

A. Mulay, B. Konda, G. Garcia…·B. Stripp

The paper develops a primary human lung epithelium infection model to study SARS-CoV-2 pathobiology and screen drugs for COVID-19.

DOI 10.1016/j.celrep.2021.109055

humanexperimental assay

𝕏 PostBluesky